TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.61% | 9.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.61% | 9.64% | |||
| Cost of Revenue | -2.52% | 9.89% | |||
| Gross Profit | -12.44% | 9.48% | |||
| SG&A Expenses | 4.37% | 1.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.23% | 4.06% | |||
| Operating Income | -36.28% | 33.25% | |||
| Income Before Tax | -36.35% | 35.64% | |||
| Income Tax Expenses | -201.02% | 28.27% | |||
| Earnings from Continuing Operations | -30.33% | 35.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.33% | 35.92% | |||
| EBIT | -36.28% | 33.25% | |||
| EBITDA | -32.22% | 28.94% | |||
| EPS Basic | -30.74% | 35.15% | |||
| Normalized Basic EPS | -36.71% | 34.87% | |||
| EPS Diluted | -28.15% | 30.83% | |||
| Normalized Diluted EPS | -36.64% | 33.49% | |||
| Average Basic Shares Outstanding | 0.59% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.47% | 1.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||